 V. Assess the change in ER, progesterone receptor PR, human epidermal growth factor receptor 2 HER2, androgen receptor AR, epidermal growth factor receptor EGFR, vascular endothelial growth factor VEGF tumor expression after two weeks of vorinostat and AI therapy in patients that consent to optional tissue biopsy procedure. 